A Prospective, Open-Label, Multicentre, Randomized, Phase III Trial to Compare the Efficacy and Safety of a Combined Regimen of Obinutuzumab and GDC-0199 (ABT-199) Versus Obinutuzumab and Chlorambucil in Previously Untreated Patients with CLL and Coexisting Medical Conditions.

Project: Research

Project Description

Monash Health HREC Ref: 14-367A
StatusActive
Effective start/end date17/07/1916/07/24

Keywords

  • clinical trial
  • treatment efficacy
  • phase 3 study
  • leukemia